Personalized drug testing for GI tumors
Part of Cancer, Digestive system clinical trials.
This trial uses a lab test to see how your tumor responds to different drugs, helping doctors choose the best treatment for you. It is for people with pancreatic cancer (PDAC) who are having surgery or a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pancreatic cancer (PDAC) and are scheduled for surgery or a biopsy of the tumor.
- You are 18 years old or older.
- You are willing and able to follow the study plan and provide samples.
- You are not pregnant, planning pregnancy, or breastfeeding.
- You do not have an active HIV, Hepatitis B, or Hepatitis C infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special test on your cancer cells to find which chemotherapy might work best for you. The aim is to treat advanced cancer that has caused fluid buildup in the chest or abdomen.
This study will take a close-up look at your pancreatic tumor by using a sample from a biopsy to create a personal profile. The goal is to understand your cancer better and maybe find the best treatment for you.
This trial grows a lab model from your own tumor tissue (or resected tissue) to predict which drugs might work best. It’s meant to match investigational treatments to your specific tumor biology.
This study tests whether using a genetic test to guide medication doses works better than standard dosing for people with certain pancreas or colon cancers. It may help by tailoring treatment more precisely to your tumor’s genetic features.
This trial tests a personalized immune therapy (like a custom vaccine) for people with colorectal cancer that has a positive ctDNA MRD test after surgery. It aims to use the body's own immune system to target any remaining cancer cells and prevent the cancer from coming back.
This study is looking at genetic material and proteins from pancreatic tumors to understand how the cancer responds to treatment. It aims to help doctors choose the best therapies for patients with certain types of pancreatic cancer that can be removed surgically or that have not spread to other organs.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.